<DOC>
	<DOCNO>NCT01463709</DOCNO>
	<brief_summary>Human Basal Cell Carcinomas ( BCCs ) ablate treat nanosecond pulse electric field ( nsPEF )</brief_summary>
	<brief_title>Development Nanosecond Pulsed Electric Field System Treat Skin Cancer</brief_title>
	<detailed_description>The purpose study determine low energy , non-thermal , 100 n pulse ablate BCCs . The investigator consider non-significant risk study PulseCure system apply 0.4 watt skin compare 40 watt apply currently use electrosurgical unit remove skin lesion , Hyfrecator . Since PulseCure apply 1/100 energy even heat skin significantly , represent non-significant risk patient . Our study provide first data response BCCs 100 n pulse . The investigator first treat three BCCs BCNS patient different pulse number determine pulse number need ablate . Once investigator optimal pulse number , investigator use treat 20 normal patient sporadic BCCs trunk . This provide sufficient data conclude whether nsPEF ablate BCCs normal individual .</detailed_description>
	<mesh_term>Carcinoma , Basal Cell</mesh_term>
	<mesh_term>Skin Neoplasms</mesh_term>
	<criteria>1 . Study subject must diagnose least one BCCon trunk 2 . The subject 1875 year age , inclusive . 3 . The subject must sign date inform consent statement . 1 . The subject exhibiting sign bacterial viral infection , include fever . 2 . The subject unwilling allow biopsy malignant lesion histological analysis . 3 . The subject pace maker electronic device implant</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>February 2013</verification_date>
	<keyword>basal cell carcinoma</keyword>
	<keyword>Basal Cell Nevus Syndrome</keyword>
	<keyword>Electric Field</keyword>
	<keyword>Nanosecond pulse</keyword>
</DOC>